Pfizer venture arm joins $25M round for Aquinox

Pfizer Venture Investments has joined a group of venture groups to provide a $25 million Series B round for Aquinox Pharmaceuticals, a Canadian start-up working on anti-inflammatories. Ventures West Capital led the round for the biotech, with Johnson & Johnson Development Corporation, Baker Brothers Investments and BC Advantage Funds joining in. "I am pleased to be joining the Aquinox Board as our investment and support will assist a team demonstrating progress in advancing SHIP1 agonists...